Lv1
60 积分 2024-12-17 加入
ON-O1, an engineered recombinant oncolytic herpes simplex virus type-1, inrecurrent glioma: a single-arm, phase 1/2 study
3个月前
已关闭
T Cell Responses to Individualized Neoantigen TherapymRNA-4157(V940)Alone or in Combination withPembrolizumab in the Phase 1 KEYNOTE-603 Study
3个月前
已完结
Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma: The CAP 03 Phase 2 Nonrandomized Clinical Trial
3个月前
已完结
皖公网安备34019202002308
